Soo-Mee Bang, M.D.
Korean J Hematol 2012; 47(3): 157-158Min Jin Kim, Hwi-Joong Yoon, and Tae Sung Park
Korean J Hematol 2012; 47(3): 161Ibrahiem Saeed-Abdul-Rahman, and Ali M. Al-Amri
Korean J Hematol 2012; 47(3): 163-177Soo-Jeong Kim, Ji Eun Jang, June-Won Cheong, Ju-In Eom, Hoi-Kyung Jeung, Yundeok Kim, Doh Yu Hwang, and Yoo Hong Min
Korean J Hematol 2012; 47(3): 178-185Suee Lee, Hyuk-Chan Kwon, Sung-Hyun Kim, Sung Yong Oh, Ji Hyun Lee, Yeon-Su Lee, Daekwan Seo, Jin-Yeong Han, and Hyo-Jin Kim
Korean J Hematol 2012; 47(3): 186-193Jong Gwon Choi, Jung-Lim Kim, Joohee Park, Soonwook Lee, Seh Jong Park, Jun Suk Kim, and Chul Won Choi
Korean J Hematol 2012; 47(3): 194-201Seok Jin Kim, Yong Park, Byung Soo Kim, Insun Kim, Young Hye Ko, and Won Seog Kim
Korean J Hematol 2012; 47(3): 202-206Min-Young Oh, Sang-Bo Oh, Hyeog-Gyu Seoung, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Kim, Moo-Kon Song, Ho-Jin Shin, and Joo-Seop Chung
Korean J Hematol 2012; 47(3): 207-212
Progression-free survival and overall survival according to SUVmax and MTD.
Progression-free survival and overall survival according to IPI score. High IPI score was defined as 3 or more. High IPI score was significantly associated with poor progression-free survival